|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-9-27
|
|
pubmed:abstractText |
The pig is an accepted species for evaluating the safety of molecules in dermal wound healing indications; however, the sizes of wounds assessed have not always been comparable to large incisions encountered clinically.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1203-4754
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
223-32
|
|
pubmed:meshHeading |
pubmed-meshheading:20868619-Animals,
pubmed-meshheading:20868619-Cicatrix,
pubmed-meshheading:20868619-Disease Models, Animal,
pubmed-meshheading:20868619-Dose-Response Relationship, Drug,
pubmed-meshheading:20868619-Female,
pubmed-meshheading:20868619-Male,
pubmed-meshheading:20868619-Recombinant Proteins,
pubmed-meshheading:20868619-Swine,
pubmed-meshheading:20868619-Transforming Growth Factor beta3,
pubmed-meshheading:20868619-Wound Healing
|
|
pubmed:articleTitle |
Effects of avotermin (transforming growth factor ?3) in a clinically relevant pig model of long, full-thickness incisional wounds.
|
|
pubmed:affiliation |
Renovo, Manchester, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
